Urinary albumin excretion: Lowering the threshold of risk in hypertension

Hypertension

Volumn 46, Issue 1, 2005, Pages 19-20

  Redon, Josep ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIABETES MELLITUS; EDITORIAL; HUMAN; HYPERTENSION; KIDNEY DISEASE; MICROALBUMINURIA; MORBIDITY; MORTALITY; POPULATION; PRIORITY JOURNAL; PROGNOSIS; URINARY EXCRETION;

ALBUMINURIA; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; RISK ASSESSMENT;

EID: 21744436610     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000169154.94803.35     Document Type: Editorial

References (10)

1. Redon J, Williams B. Microalbuminuria in essential hypertension. Redefining the threshold. J Hypetens. 2002;20:353-355.
2. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.
3. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol. 1999;19:1992-1997.
4. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19:617-624.
5. Roest M, Banga JD, Janssen WM, Grobbee DE, Sixma JJ, de Jong PE, de Zeeuw D, van Der Schouw YT. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation. 2001;103:3057-3061.
6. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. J Am Med Assoc. 2001;286:421-426.
7. Klausen KP, Scharling H, Jensen G, Jensen JS. New definition of microalbuminuria in hypertensive subjects: Association with incident coronary heart disease and death. Hypertension. 2005;46:33-37.
8. Pascual JM, Rodilla E, Gonzalez C, Perez-Hoyos S, Redon J. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension. 2005;45:1125-1130.
9. Ibsen H, Olsen MH, Wachteil K, Borch-Johnnsen K, Lindholm luteinizirig hormone (LH), Mogensen CE, Dahlof B, Devereux RB, de Faire U, Fyhrquist F, Julius S. Kjeldsen SE, Lederballe-Pedersen O. Nieminen MS, Omvik P, Oparil S, Wan Y. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: a LIFE study. Hypertension. 2005;45:198-202.
10. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110:921-927.